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Abstract The protein NDRG2 (N-myc downregulated gene 2)
is expressed in astrocytes.We show here that NDRG2 is located
in the cytosol of protoplasmic and fibrous astrocytes throughout
the mammalian brain, including Bergmann glia as observed in
mouse, rat, tree shrew, marmoset and human. NDRG2 immu-
noreactivity is detectable in the astrocytic cell bodies and ex-
crescencies including fine distal processes. Glutamatergic and
GABAergic nerve terminals are associated with NDRG2
immunopositive astrocytic processes. Müller glia in the retina
displays no NDRG2 immunoreactivity. NDRG2 positive astro-
cytes are more abundant and more evenly distributed in the
brain than GFAP (glial fibrillary acidic protein) immunoreac-
tive cells. Some regions with very little GFAP such as the
caudate nucleus show pronounced NDRG2 immunoreactivity.
In white matter areas, NDRG2 is less strong than GFAP label-
ing. Most NDRG2 positive somata are immunoreactive for
S100ß but not all S100ß cells express NDRG2. NDRG2 pos-
itive astrocytes do not express nestin and NG2 (chondroitin
sulfate proteoglycan 4). The localization of NDRG2 overlaps
only partially with that of aquaporin 4, the membrane-bound
water channel that is concentrated in the astrocytic endfeet.
Reactive astrocytes at a cortical lesion display very little
NDRG2, which indicates that expression of the protein is
reduced in reactive astrocytes. In conclusion, our data show
that NDRG2 is a specific marker for a large population of
mature, non-reactive brain astrocytes. Visualization of
NDRG2 immunoreactive structures may serve as a reliable tool
for quantitative studies on numbers of astrocytes in distinct
brain regions and for high-resolution microscopy studies on
distal astrocytic processes.
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Introduction
There is an increasing interest in the role of glia in brain pathology,
e.g., with respect to psychiatric disorders (Banasr et al. 2010; Czéh
et al. 2013). In the hippocampus of patients withmajor depression
(MD), glia cells and neurons are more densely packed than in
healthy controls (Stockmeier et al. 2004). To analyze brains of
patients post-mortem, antibodies against astrocytic marker pro-
teins such as GFAP (glial fibrillary acidic protein) have been used
in previous studies. GFAP immunoreactivity was found to be
significantly reduced in hippocampal regions CA1 and CA2 as
well as in the left orbitofrontal cortex ofMDpatients (Muller et al.
2001; Miguel-Hidalgo et al. 2010). However, since GFAP is a
structural protein of intermediate filaments and as such constitutes
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only approximately 15 % of the total astrocytic volume,
concentrations of this protein might not always be directly
related to the numbers of astrocytes present in the respective
brain region (Bushong et al. 2002; Lavialle et al. 2011).
Moreover, GFAP expression is enhanced under pathological
conditions that are accompanied by gliosis. This may lead to
the detection of high GFAP concentrations in psychiatric
patients with a gliosis, which may not necessarily be related
to the respective psychiatric disease. Therefore, additional
glial marker proteins are needed as tools for the visualization
of glial cells.
It has been shown that antibodies against the cytosolic
protein NDRG2 label brain glia cells (Okuda et al. 2008).
Ndrg2 belongs to the family of N-myc downregulated genes
and is expressed in a variety of tissues throughout the body
and central nervous system including glia (Okuda and
Kondoh 1999; Wielpütz et al. 2007; Zhang et al. 2006).
Functions of Ndrg2 still remain to be elucidated but the gene
has attracted particular attention because numerous studies
have indicated that the NDRG2 protein is a tumor suppressor
(Hwang et al. 2011). Transfection of human glioblastomawith
Ndrg2 cDNA reduced cell proliferation while low NDRG2
has been detected in colon carcinoma (Kim et al. 2009; Deng
et al. 2003). However, Ndrg2mRNAwas also found in many
brain regions of healthy rats (Nichols 2003). Analysis of the
fetal mouse revealed NDRG2 protein after embryonic day
13.5 with an increase in expression during the late stages of
development (Hu et al. 2006). This developmental profile
coincides with data indicating that NDRG2 plays a role in cell
differentiation and studies in fetal mice have shown that a lack
of Ndrg2 leads to vertebral homeosis (Okuda et al. 2008; Zhu
et al. 2012). Since adenovirus-mediated NDRG2 over-
expression reduced the number of 5-bromo-2′-deoxy-uri-
dine-incorporating cells in cultured astrocytes and enhanced
the amount of F-actin, it was proposed that the gene sup-
presses proliferation and stabilizes morphology of cells
(Takeichi et al. 2011). Our previous article showed that
NDRG2 protein expression is enhanced in the hippo-
campus of chronically stressed rats (Araya-Callís et al.
2012). The aim of the present study is to analyze in
which type of astrocytes the protein is expressed by
comparing the pattern of NDRG2 immunoreactivity with
that of other astrocytic marker proteins in mouse, rat,
tree shrew, marmoset and human.
Materials and methods
Experimental animals
Five adult male C57BL/6 mice (22±2 g) were obtained from
The Jackson Laboratory (http://www.jax.org/). Five adult
male Wistar rats (225±6 g) were obtained from Harlan
Winkelmann, Borchen, Germany. Five adult tree shrews
(Tupaia belangeri), 3 females, 2 males, 190±5 g, were
obtained from the breeding colony at the German Primate
Center, Göttingen, Germany. Housing of tree shrews has
been described before (Fuchs and Corbach-Söhle 2010).
Three adult marmoset monkeys (Callithrix jacchus), 1 female,
2 males (350–480 g) were obtained from the breeding colony
at the German Primate Center. Housing of marmosets has
been described before (Mitura et al. 2012). Two marmosets
received a brain lesion with 6-hydroxydopamine (6-OHDA)
(see below). All animal experiments were performed in ac-
cordance with the European Commission directive 2010/63/
EU (from September 22, 2010) and were approved by the
Lower Saxony Federal State Office for Consumer Protection
and Food Safety, Germany.
Cortical lesion
To analyze NDRG2 at a glial scar induced by physical trauma,
we used brain sections from marmosets that had received 6-
OHDA lesions in the caudate nucleus within a project not
related to the present study. The neocortices of these animals
displayed glial scars that were primarily caused by the pene-
trations of the injection needles. Two male marmosets re-
ceived unilateral 6-OHDA lesions using a modified protocol
based on Annett et al. (1992, 1995). The surgery was per-
formed under deep anesthesia. As initial medication, animals
received alphaxalon, diazepam and glycopyrronium bromide
as described before (Ribic et al. 2011). After intratracheal
intubation, they were inhaled with N2/O2 (70/30) and
isoflurane (0.5–1.5 %) using a respirator (Animal Respirator;
TSE, Bad Homburg, Germany). 6-hydroxydopamine
hydrobromide (H-8523; Sigma-Aldrich, Steinheim,
Germany) was dissolved in 0.01 % ascorbate saline and the
toxin (5 μg in 3.0 μl) was injected stereotaxically into the
caudate nucleus, at 6 sites in one hemisphere. Coordinates
were determined with a marmoset brain atlas (Stephan et al.
1980); first site, AP +8.0, L +2.5, V +12.5; second site, AP +
8.0, L +3.5, V +13.5; third site, AP +9.0, L +2.5, V +12.0;
fourth site, AP +9.0; L +3.5, V +13.0; fifth site, AP +10.0, L +
2.25, V +12.0 and sixth site, AP +10.0, ML +3.25, V +13.0).
The injections were performed with glass capillaries at a rate
of 0.5 μl/min using Nano injector 2000 (WPI, Berlin,
Germany). After each injection, the capillary remained in
place for 4 min. After the surgery, the monkeys were kept in
a warm incubator until they were well enough to be returned
to their home cages. They were treated with meloxicam
(0.2 mg/kg i.m.; Metacam®; Boehringer Ingelheim,
Germany) for 3 days and with enrofloxacin (5 mg/kg i.m.;
Baytril®; Bayer, Germany) for 5 days. 19 weeks after the
surgery, the animals were sacrificed and their brains perfused
as described below.
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Tissue preparation and perfusion
For fixation of the brains, rodents and tree shrews were deeply
anesthetized with a mixture of GM II (Göttinger Mischung II:
xylazine, 50 mg/mL; ketamine, 10 mg/mL; atropine, 0.1 mg/
mL). Two male marmosets were anesthetized with GM II and
received, after loss of consciousness, an intraperitoneal injec-
tion of ketamine (400 mg/kg body weight). Bodies were
transcardially perfused with cold (4 ºC) saline (0.9 % NaCl)
for 2 min (mice), 3 min (rats, tree shrews) or 5 min
(marmosets). Subsequently, for fixation of the brains, cold
(4 ºC) 4 % paraformaldehyde (PFA) in 0.1 M phosphate
buffer, pH 7.2, was infused for 5 min (mice), 10 min (rats,
tree shrews) or 15 min (marmosets). The heads were post-
fixed in fresh 4 % PFA at 4 ºC overnight. The following day,
brains were removed from the skulls and immersed in 30 %
sucrose in PBS (phosphate buffered saline: 0.137 M NaCl,
2.7 mM KCl, 4.3 mM Na2HPO4 x 12H2O, 1.4 mM KH2PO4;
pH 7.2) and incubated at 4 ºC for 2 days (for cryoprotection).
Pieces of the brains were then frozen on dry ice and stored at
−80 ºC until coronal sectioning was performed on a Leica
cryostat (CM3050S; Leica Biosystems, Nussloch, Germany)
at a thickness of 40 μm. Anatomical levels were chosen with
brain atlases for the different species (mouse, Paxinos and
Franklin 2008; rat, Paxinos and Watson 1986; tree shrew,
Tigges and Shanta 1969; marmoset, Stephan et al. 1980).
Retinae were dissected from a female marmoset that
had not been perfused. Euthanasia was performed with
an overdose of GMII and ketamine as indicated above.
Eyes were dissected immediately post-mortem and eye
balls were frozen over liquid nitrogen. Cryostat sections
(40 μm) were generated from the frozen eye balls and
mounted on glass slides (Histobond; Marienfeld, Lauda-
Königshofen, Germany) directly before the immunocy-
tochemical treatment. Sections were mounted on glass
slides and fixed with phosphate-buffered 4 % PFA for
2 min. The immunofluorescence experiments were per-
formed as described below.
Human brain stem sections were derived from autopsy
material generated and analyzed before in the Department of
Neuropathology, University Medical Center, Göttingen
(Singh et al. 2013). Specimen were post-fixed in phosphate
buffered 4 % PFA, and were immersed in 30 % sucrose in
PBS for cryoprotection and subsequent cutting in a cryostat
(40-μm sections).
Immunohistochemistry for light microscopy
Cryostat sections from perfusion fixed brains were
immunohistochemically processed. Sections were washed in
PBS and incubated in 1 % H2O2 (in PBS) for 30 min to
inactivate endogenous peroxidase activity. All following
washing steps were performed 3 times, 10 min each, in PBS.
To block potential nonspecific antibody binding, sections
were then incubated in 3 % NGS (normal goat serum;
Vector Laboratories, Burlingame, CA, USA) in PBS with
0.3 % Triton X-100, for 1 h. Subsequently, sections were
incubated with either the mouse polyclonal anti-NDRG2 an-
tibody (H00057447-A01; Abnova, Taiwan, http://www.
abnova.com; working dilution 1:1,000) or goat polyclonal
anti-NDRG2 (sc-19468; Santa Cruz Biotechnology Inc.,
http://www.scbt.com, working dilution 1:1.000) in PBS-
NGS-T (1 % normal goat serum, 0.3 % Triton X-100 in
PBS) overnight at 4 ºC. After washing, the sections were
incubated with secondary antibodies: biotinylated goat anti
mouse IgG (BA-9200, Biozol; Diagnostica Vertrieb, Eching,
Germany, working dilution 1: 400) or biotinylated horse anti
goat IgG (BA-9500, Biozol, working dilution 1:400) in PBS-
NGS-T, for 2 h. Subsequently, the sections were washed and
incubated with the avidin-biotin complex (ABC Kit; Vector
Laboratories) in PBS with 3 % NGS, for 1.5 h, according to
the producer’s instructions. Finally, antibody binding was
visualized with the chromogen 3,3′-diaminobenzidine (DAB
Peroxidase Substrate Kit; Vector Laboratories) 0.025 %, with
0.01 % H2O2 as a catalytic agent. The sections were then
washed, mounted on glass slides and left to dry overnight at
37 ºC. Dry sections were cleared in xylene and cover slipped
with mounting medium (Eukitt; Sigma-Aldrich). Sections
were examined with an Axiophot II microscope using a
Plan-Apochromat ×63 oil immersion objective (NA 1.4)
(Carl Zeiss Microimaging, Göttingen, Germany).
Immunofluorescence and confocal microscopy
Cryostat sections (40 μm) from perfusion fixed brains were
processed in the immunofluorescence experiments. Primary an-
tibodies against the following antigens were used: NDRG2,
mouse (ms) polyclonal (pc) antibody (ab) (# H00057447-A01;
Abnova), working dilution 1:1,000; NDRG2, goat pc ab (# sc-
19468; Santa Cruz Biotechnology), 1:1,000; aquaporin 4
(AQP4) rabbit (rb) pc ab (# AB3594; Millipore/Chemicon,
http://www.millipore.com), 1:1,000; GFAP, ms mc ab (# G
3893; Sigma-Aldrich), 1:5,000; Iba1, rb pc ab (019–19741;
Wako), 1:2,000; MAP2 (microtubule-associated protein 2), rb
pc ab (AB5622; Chemicon), 1:1,000; nestin, ms mc ab (#
312011; Synaptic Systems, Göttingen, Germany), 1:1,000;
NG2, rb pc ab (# AB5320; Chemicon), 1:500; NSE (neuron-
specific enolase), rb pc ab (#AB951;Chemicon), 1:2000; S100ß,
rb pc ab (# ab 7853–500; Abcam), 1:2,000; S100ß, rb pc ab (#
15146-1-AP; Proteintech), 1:1000; VGAT (vesicular GABA
transporter), rb pc ab (# 131003; Synaptic Systems), 1:1000;
VGLUT1 (vesicular glutamate transporter 1), rb pc ab (#
135302; Synaptic Systems), 1:500; VIM, vimentin, rb pc ab
(#172002; Synaptic Systems), 1:500. Fluorescent secondary an-
tibodies were the following: Alexa 488-coupled donkey anti rb
IgG,Alexa 488-coupled donkey anti ms IgG,Alexa 594-coupled
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donkey anti ms, and Alexa 594 donkey anti goat IgG (Molecular
Probes, Invitrogen, Leiden, Netherlands), working dilution 1:500
in all cases. In double-labeling experiments, antibodies were
applied sequentially and blocking steps were performed using
normal serum of the host species from which the respective
secondary antibody was derived. Sections were processed as
described before (Araya-Callís et al. 2012). After incubation with
the antibodies, sections were washed in PBS and floated/
mounted on Histobond slides in distilled water, allowed to dry
overnight at 4 °C and cover-slipped with mounting medium
(Aqua-Polymount; Polysciences, Warrington, PA, USA).
Confocal microscopy was performed with a laser scanning
microscope (LSM 5 Pascal; Carl Zeiss Microscopy, Germany)
with argon (488 nm) and helium/neon (543 nm) lasers.
Confocal analysis was performed in multiple-tracking mode
using an Apochromat 63 oil objective (NA=1.4) with oil
immersion (Immersol, Zeiss, refractive index=1.518). The
543-nm laser was always used with a smaller detection pin-
hole diameter than the 488-nm laser to produce optical sec-
tions of comparable thickness for co-localization analysis.
Results
Overall pattern of NDRG2 immunoreactivity
Brain sections that were immunohistochemically processed
for light microscopy show that NDRG2 immunoreactive cells
are more evenly distributed than GFAP-positive cells (Fig. 1,
Table 1). A section from the mouse brain reveals a quite
homogeneous NDRG2 staining pattern generated by the im-
munoreactive cell bodies. The staining patterns of the hippo-
campal formation are similar in mouse and rat (Fig. 1), as well
as in the tree shrew (not shown). Light microscopy shows a
light brown background, which is due to a large number of
fine immunoreactive processes that can be distinguished when
labeled for immunofluorescence in the confocal microscope
(see below). White matter regions such as the corpus callosum
display low levels of NDRG2 immunoreactivity, while layers
with accumulated neurons (e.g., pyramidal neuron layer in
CA1, granule cell layer of the dentate gyrus) are unstained. In
the rat brain, the staining appears evenmore homogenous than
in the mouse and a similar NDRG2 staining pattern is found
in marmoset brain sections (Fig. 1; Supplementary Figure S1).
The human brain stem shows a similar labeling as the mouse
brain stem with a dense array of NDRG2 immunoreactive
fibers and some cell bodies (Supplementary Figure S1). Both
NDRG2 antibodies used in the present study generated the
same staining pattern and there was total co-localization in
double-immunofluorescence experiments (not shown).
NDRG2 compared to GFAP immunofluorescence
Astrocytes are differentially labeled by antibodies against
NDRG2 and GFAP, respectively (Fig. 2, Table 1). There are
cell bodies in the caudate nucleus that show intense NDRG2
Fig. 1 Overview of NDRG2 and
GFAP immunoreactivity in brains
of mouse, rat and marmoset.
Sections from the level of the
hippocampus were
immunohistochemically
processed for light microscopy.
aMouse, NDRG2
immunoreactivity; the inset




(a) is more evenly distributed
throughout gray matter areas than




cornu ammonis regions 1 and 3;
CC corpus callosum; DG dentate
gyrus; hil hilus; Ncx neocortex.
Calibration bars 200 μm
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but little GFAP (Fig. 2a). In cortical layer III, there are cells
whose entire cell bodies and processes contain NDRG2 but
only a few GFAP-positive intermediate filaments (Fig. 2c). In
contrast, the cortical layer I is characterized by a dense pattern
of GFAP-positive fibers with little NDRG2 confined to the
cell bodies (Fig. 2b). The fibrous astrocytes in the corpus
callosum contain either both antigens or predominantly
GFAP (Fig. 2d). The presence of cells showing no or only
partial co-localization indicates that the two proteins are either
expressed in different cell populations or in astrocytes of
distinct physiological/metabolic states.
Glial scar
To test whether NDRG2 is expressed in reactive astrocytes,
sections from a marmoset with a trauma-induced lesion in the
neocortex were analyzed. In the area around the lesion, three
zones can be depicted: (1) the zone directly at the lesion, which
represents the glial scar and is rich in GFAP but contains
almost no NDRG2 (Fig. 3, right side in a, b); (2) the
zone in the periphery of the scar where there is very
little GFAP but pronounced NDRG2 expression (Fig. 3,
left side in a, b) and (3) a narrow band between the
scar and the periphery in which cells show immunoreac-
tivity for both antigens (Fig. 3a, middle part). It thus appears
that astrocytes forming the glial scar contain very little
NDRG2, which indicates that expression of this protein is
reduced in reactive astrocytes. Moreover, there is almost no
NDRG2 in the cells at the surface of the lesion where vimentin
immunoreactivity is strong (Fig. 3d). Some cells in the zone of
the glial scar express nestin but also these cells show no
NDRG2 (Fig. 3c).
NDRG2 and other glial or neuronal markers
NDRG2 co-localizes with S100ß in most gray matter astro-
cytes as shown in the neocortex (Fig. 4). In contrast, in white
matter areas, there is only partial co-localization in distinct
Table 1 Distribution of NDRG2 in comparison with other cell markers
Antigen 1 Antigen 2 Brain regions analyzed Species analyzed Results
NDRG2 – All regions Mouse, rat, tree shrew, marmoset, human Astrocytes are NDRG2+; distribution of NDRG2+ cells
more homogeneous than distribution of GFAP+ cells
NDRG2 GFAP All regions Mouse, rat, tree shrew, marmoset Co-localization in most astrocytes; NDRG2 in cytosol
of cell bodies and astrocytic processes, GFAP in
intermediate filaments
NDRG2 GFAP Caudate nucleus Rat, tree shrew, marmoset Moderate density of NDRG2+ cells, low density
of GFAP+ cells
NDRG2 GFAP White matter Rat, tree shrew, marmoset Low density of NDRG2+ cells, moderate density
of GFAP+ cells
NDRG2 S100ß Gray matter areas Rat Co-localization in astrocytes
NDRG2 S100ß White matter Rat Co-localization in a subpopulation of astrocytes
NDRG2 AQP4 All regions Rat, tree shrew Partial co-localization
NDRG2 NG2 All regions Rat, tree shrew No co-localization
NDRG2 Iba1 All regions Rat, tree shrew No co-localization
NDRG2 Nestin Lesion in the neocortex;
dentate gyrus
Marmoset No co-localization
NDRG2 VIM Lesion in the neocortex,
glial scar
Marmoset No co-localization
NDRG2 – Retina Tree shrew, marmoset No NDRG2 in Müller glia; low NDRG2 expression
in ganglion cell layer
NDRG2 NSEa All regions Rat, tree shrew, marmoset No co-localization
NDRG2 MAP2a All regions Rat, tree shrew No co-localization
NDRG2 VGlut1a Cerebellum, hippocampus Rat No co-localization; Bergmann glia cells are
NDRG2+; association of NDRG2+ processes
with VGlut1+ terminals
NDRG2 VGAT Cerebellum, hippocampus Rat No co-localization; association of NDRG2+ astrocytic
processes with VGAT+ terminals
AQP4 aquaporin 4;GFAP glial fibrillary acidic protein; Iba1 ionized calcium-binding adapter molecule 1;NG2 chondroitin sulfate proteoglycan 4;NSE
neuron specific enolase; MAP2 microtubule-associated protein 2; VGAT vesicular GABA transporter; VGlut1 vesicular glutamate transporter 1; Vim
vimentin; + immunopositive
a Neuronal marker
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cells. The subcellular localization of the two antigens differs
as, e.g., demonstrated in the corpus callosum where certain
cell bodies are entirely stained for S100ß but only partially for
NDRG2 and some astrocytic processes display solely S100ß
immunoreactivity (Fig. 4b–d). S100ß is also strongly
expressed in the cells forming the glial scar, which display
no NDRG2 immunoreactivity (Supplementary Fig. S3d).
The water channel aquaporin 4 (AQP4), which is located in
the astrocytic plasma membrane and is concentrated in endfeet,
co-localizes partially with the cytosolic protein NDRG2
(Fig. 5). Small capillaries are easily distinguishable because
of their AQP4-positive astrocytic endfeet, which terminate on
the walls of these capillaries (Fig. 5a, d). The wall of a large
blood vessel shows a dense pattern of NDRG2 immunoreactive
astrocytic processes (Fig. 5c). A fine line of yellow fluores-
cence around an astrocyte in hippocampal region CA3 indi-
cates a close vicinity of the NDRG2 and the S100ß antigen.
NDRG2 does not co-localize with the neuronal markers
NSE (neuron-specific enolase) and MAP2 (microtubule-
associated protein 2) (Supplementary Figure S2). There is also
no co-localization with the ‘neuroglia’ marker NG2 or with
the microglia marker Iba1 (ionized calcium-binding adapter
molecule 1) (Supplementary Figure S3a, c). In brains of adult
marmosets, nestin immunoreactive fibers were also detected
close to the brain surface at the ventromedial pole of the
dentate gyrus. However, no co-localization with NDRG2
was observed indicating that the nestin-positive fibers do not
belong to NDRG2 cells (Supplementary Figure S3b).
Astrocytic processes at nerve terminals
Bergmann glial cells strongly express NDRG2 (Fig. 6). In the
cerebellar granule cell layer, the immunoreactive processes of
astrocytes are located close to the mossy fiber terminals that are
stained by the antibody against the vesicular glutamate transport-
er 1 (VGLUT1) (Fig. 6b). Similarly, NDRG2 containing astro-
cytic processes are associated with glutamatergic nerve terminals
in the hippocampal stratum lucidum (Fig. 6c). NDRG2-positive
processes are also associated with GABAergic nerve terminals,
which are stained for the vesicular GABA transporter (VGAT) as
shown in the stratum lucidum (Fig. 6d, Table 1).
Retina
Preliminary experiments revealed that GFAP and NDRG2
immunoreactivity in the retina are fixation-sensitive. For this
Fig. 2 NDRG2 (red) and GFAP (green) immunoreactivity in marmoset
(a, b, d) and tree shrew (c). a Caudate nucleus; note the strong NDRG2
immunoreactivity of the astrocytic cell body (asterisk) and the array of
fine fibers in the surroundings of the cell; arrow denotes a GFAP immu-
noreactive fiber. b Cortical layer I; only a few cell bodies (asterisk)
displayNDRG2 immunoreactivitywhereas GFAP-positive fibers (arrow)
are abundant. c Cortical layer III; an immunoreactive NDRG2-positive
astrocyte (asterisk) is located close to a blood vessel (BV). d Border
between corpus callosum (CC) and caudate nucleus (CD); note that in
the CC, there are cells stained for both antigens (asterisk) as well as cells
in which GFAP dominates (arrow head). Very low GFAP immunoreac-
tivity is found in the CD
Fig. 3 Glial scar at a trauma-induced lesion in the marmoset neocortex. a
Merged NDRG2 and GFAP immunofluorescence; GFAP-positive cells
are accumulated in the area of the glial scar (glsc); note the narrow zone
where cells are immunoreactive for both NDRG2 and GFAP (asterisk). b
Red NDRG2 immunofluorescence (channel corresponding to a); within
the glial scar, there are only a few cells that express NDRG2 (right). c
Merged NDRG2 and nestin immunofluorescence; the nestin immunore-
active cells (arrow) in the area of the glial scar do not express NDRG2. d
(merged): Vimentin and NDRG2 at the surface of the glial scar; note that
there is a fine vimentin immunoreactive fiber network and almost no
NDRG2
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reason, we generated sections from freshly frozen marmoset
retinae and post-fixed them only briefly with 2 % PFA (see
“Materials and methods”). With this approach, GFAP and
vimentin immunoreactivity can be detected in the retinal
layers (Fig. 7). Clusters of GFAP positive fibers are present
in the inner nuclear layer (INL), which contains the Müller
cells bodies as well as in the nerve fiber (NFL) and ganglion
cell layer (GCL) (Fig. 7a). In contrast, no NDRG2 immuno-
reactivity is found in the INL. Furthermore, only traces of
NDRG2 immunofluorescence are visible in the NFL/GCL,
possibly representing small amounts of the antigen in astro-
cytes (Fig. 7b). Only connective tissue in the choroid displays
pronounced NDRG2 immunoreactivity. Vimentin is present
throughout all layers of the retina (Fig. 7c). However, the
strong fluorescence of the retinal pigment epithelium (RPE)
and of the adjacent outer nuclear layer (asterisk) is nonspecific
as it is also visible in control sections incubated with only the
secondary antibodies (Fig. 7d).
Discussion
The present data reveal NDRG2 expression in a large popu-
lation of brain astrocytes. These cells are relatively homoge-
neously distributed throughout gray matter areas. NDRG2
expressing astrocytes also contain S100ß but the NDRG2
cells appear to represent a different population from the
S100ß cells. Fibrous astrocytes of white matter express
NDRG2 less strongly than GFAP. No or very low NDRG2
is found in reactive astrocytes. Our findings thus show that
NDRG2 is a suitable marker for mature, non-reactive brain
astrocytes.
After injury to the brain, mature astrocytes in the area of the
lesion can de-differentiate to cells that form a scar (Wachter
et al. 2010). The present data reveal that NDRG2 is almost
absent from the astrocytes that form the glial scar around a
trauma-induced lesion in the marmoset neocortex, indicating
that NDRG2 expression is downregulated in reactive astro-
cytes. It has been proposed that, in the area of a lesion,
inflammatory mediators derived from blood-borne and
injury-associated cells regulate astroglial transcription, prolif-
eration and function (Wanner et al. 2013). Serious insults
such as trauma, ischemia, or autoimmune inflammation in-
duce proliferation of astrocytes and other cells, which leads to
formation of the glial scar (Sofroniew 2009). Expression of
the progenitor and radial glial marker vimentin and of GFAP
strongly increases after injury to the brain (Bramanti et al.
2010; Kim et al. 2012). The population of astrocytes in the
Fig. 4 S100ß and NDRG2 immunoreactivity in the rat brain. a (merged)
Neocortex layer III; most labeled cells (asterisk) are immunoreactive for
both antigens (yellow). b (red channel) Corpus callosum; NDRG2 ex-
pression in some cells is relatively weak (arrow). c Green channel
(corresponding to b): The cell that is also indicated in (b) (arrow)
shows a pronounced S100ß expression; arrowhead denotes S100ß im-
munoreactive fiber. d (merged) The cell that is also indicated in (b and c)
shows strong S100ß but weak NDRG2 immunoreactivity; arrowhead
denotes S100ß immunoreactive fiber that does not contain NDRG2
Fig. 5 Partial co-localization of NDRG2 and AQP4 immunoreactivity. a
(merged) Tree shrew neocortical layers I-III; note the array of punctual
AQP4 immunoreactivity and some NDRG2-positive cell bodies
(asterisk); the wall of a large blood vessel (BV) displays NDRG2 immu-
noreactive structures; Cap capillary. b Red channel corresponding to (a).
c (merged) High magnification of a blood vessel in tree shrew cortical
layer III; arrow indicates astrocytic process at the wall of the blood vessel;
note that there is only partial co-localization with AQP4 (yellow struc-
tures). d (merged) Rat hippocampal region CA3; note the NDRG2
immunoreactive cell body (asterisk); co-localization with AQP4 is indi-
cated by the fine yellow line that surrounds the NDRG2 immunoreactive
cell body. Pyr pyramidal neuron layer
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area of a glial scar is heterogeneous and varies with the
distance from the scar. At least two categories of reactive
astrocytes have been observed in such an area: (1) newly
proliferated, elongated astrocytes that form the scar and (2)
hypertrophic stellate, reactive astrocytes that do not proliferate
and derive from local astroglia (Wanner et al. 2013).
Accordingly, in the marmoset neocortex, cells expressing
vimentin were detected directly at the lesion. Also, cell bodies
immunoreactive for nestin, the stem cell-associated interme-
diate filament protein that is expressed during development,
have been observed at a glial scar (Pekny and Pekna 2004). In
the present study, nestin-positive cells were located at some
distance from the lesion. None of these cells expressed
NDRG2 and, furthermore, NDRG2 was not found in the
strongly GFAP immunoreactive astrocytes. Co-localization
of NDRG2 and GFAP was only detected in cells within a
narrow zone between the area of the scar and the surrounding
unaffected tissue. It appears that the astrocytes in that narrow
zone are in a transient situation between a quiescent and
reactive state. They possibly represent resident astrocytes that
are about to de-differentiate in the process of astrogliosis
(Wachter et al. 2010).
As a structural protein of intermediate filaments (IF),
GFAP may play a role in IF rearrangements during astrocyte
migration (Lepekhin et al. 2001). Over-expression of the
protein in mouse models of Alexander Disease induced hy-
pertrophic astrocytes that had lost their bushy appearance
due to a lack of fine distal processes (Messing and Brenner
2003; Sosunov et al. 2013). GFAP in reactive astrocytes is
thus associated with proliferation and allows cell migration in
the course of brain tissue regeneration. In contrast, NDRG
may suppress proliferation and may stabilize cell morphology
(Takeichi et al. 2011). It is also interesting to note that, in vitro,
Ndrg2 gene induction by a growth factor enhanced sprouting
and extension of cell processes in another cell type, PC 12
cells (Takahashi et al. 2005). Furthermore, studies on skeletal
muscle tissue provided indications that increased levels of
NDRG2 do not stimulate proliferation but are related to ho-
meostasis of the cells, in this case myotube function (Foletta
et al. 2009). One may speculate that brain astrocytes with
normal levels of NDRG2 are in a ‘non-reactive’ state that
allows their homeostatic functioning within the neural net-
work. However, it remains to be determined whether this
‘non-reactive’ state is related to the mechanisms through
which NDRG2 suppresses cell proliferation.
Fig. 6 Glia cells in rat cerebellum and hippocampus. a (merged) Cere-
bellar Purkinje cell layer (Pcl); note the stronglyNDRG2 immunoreactive
Bergmann glia cell bodies (asterisk) that are located between the
unlabeled Purkinje neurons (Pkj); Bergmann glial fibers (Bgf; red) in
the molecular layer (ml) are associated with the glutamatergic parallel
fibers (green); gcl granule cell layer. b (merged) Layer of granule cells
(gc) in the cerebellum; note the NDRG2 process (arrow), which is
associated with a VGLUT1 immunoreactive mossy fiber terminal (mft).
c (merged) Hippocampal stratum lucidum; note the fine NDRG2 positive
process (arrow), which is associated with the giant VGLUT1 immuno-
reactive mossy fiber terminal (mft) that synapses on dendrites (D) of
pyramidal neurons (Pyr). d (merged) Hippocampal stratum lucidum; note
that fine NDRG2 positive processes are associated with VGAT immuno-
reactive nerve terminals; asterisk indicates NDRG2 immunoreactive cell
body
Fig. 7 NDRG2 and GFAP in the marmoset retina. a (merged) NDRG2
and GFAP immunoreactivity. b (red channel corresponding to a) Arrows
denote faint NDRG2 immunoreactivity. c (merged) NDRG2 and
vimentin (VIM) immunoreactivity. d (merged) Control section incubated
with just the secondary antibodies. Asterisks denote an outer nuclear layer
that displays nonspecific immunofluorescence. Chor choroid; GCL gan-
glion cell layer; INL internal nuclear layer; NFL nerve fiber layer; ON
optic nerve; R retina (all layers); RPE retinal pigment epithelium. Cali-
bration bars 50 μm
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Expression of the calcium binding protein S100ß charac-
terizes cells that lose their neural stem cell potential and
acquire a mature developmental stage (Raponi et al. 2007).
The present data confirm previous findings showing that
S100ß is expressed in a large population of astrocytes
(Adami et al. 2001). In the frontal brain, NDRG2 co-
localizes with S100ß in the majority of cells. However, the
subcellular localization of the two proteins differs in that
NDRG2 is only found in the cytosol whereas S100ß is also
associated with subcellular membranes and the cytoskeleton
(Adami et al. 2001). Another difference between the two
proteins is that S100ß is increased in reactive astrocytes
whereas NDRG2 is not. However, S100ß antibodies may
not only label astrocytes but also certain neurons, presumably
because of cross-reactivity of respective antibodies with dif-
ferent members of the S100 gene family (Rickmann andWolff
1995a). Coinciding with this, we observed strong S100ß
immunoreactivity in certain brain stem neurons such as the
motor neurons of the trigeminal nucleus (not shown). A
further complication in experiments with S100ß antibodies
is that the intensity of the immunoreactvity is sensitive to the
tissue fixation (Rickmann and Wolff 1995b). In view of such
potential problems with S100ß antibodies, one may regard
NDRG2 as a more reliable marker for mature brain astrocytes.
The present study shows that NDRG2 is strongly expressed
in Bergmann glia cells that are known to interact with the
Purkinje neurons (Bellamy 2006). We visualized glutamater-
gic and GABAergic nerve terminals with antibodies against
the vesicular glutamate transporter and the vesicular GABA
transporter, respectively. In the confocal microscope, NDRG2
was found to be closely associated with these nerve terminal
markers indicating that the protein is present in the fine distal
astrocytic processes that contact nerve terminal structures
including synapses (Araque et al. 1999; Haydon 2001). In
contrast, GFAP that constitutes only ∼15 % of the total
volume of an astrocyte is not found in the distal astrocytic
processes that contact synapses (Bushong et al. 2002; Lavialle
et al. 2011).
It is interesting to note that NDRG2 has been shown to
interact with a subunit of sodium-potassium ATPase, at least
in epithelial cells (Li et al. 2011). The astrocytic ATPase is
important for the regulation of neurotransmission as it restores
the ion gradient necessary to drive glutamate transport
(Haydon and Carmignoto 2006; Pellerin and Magistretti
1997). However, the numerous interactions between neurons
and glia cells are not confined to synaptic structures but
‘convoluted cytoplasmic tongues’ of astrocytes appear to
‘branch randomly into the neuropil’ (Reichenbach et al.
2010). The cytosolic protein NDRG2 may thus be a suitable
marker to visualize sites of interactions between astrocytic and
neuronal structures.
The architecture of the marmoset retina has been described
before (Hendrickson et al. 2006). We observed strong GFAP
and vimentin staining of all retinal layers including the inner
nuclear layer that contains the somata of Müller cells
(Bringmann et al. 2013). However, the NDRG2 antibody did
not label the Müller cells. Only the nerve fiber/ganglion cell
layer showed a minor immunofluorescence, probably related
to astrocytes. It is interesting to note that NDRG2, which is a
suppressor of cell proliferation, displays such a low level of
expression in the retina, a tissue with a high potential of cell
regeneration (Lewis and Fisher 2003). This finding provides
further evidence that NDRG2 is not expressed in proliferating
glia cells.
In conclusion, our results show that NDRG2 is a marker for
mature, nonreactive, non-proliferating astrocytes. Antibodies
against this marker protein may be suitable for a morpho-
logical analysis of the respective subpopulation of astrocytes.
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